From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Allergan Inc.

www.allergan.com

Most Recent Related Deals

Allergan licenses Serenity's Phase III Ser120, 4/2010
Allergan sublicenses neuropathic pain agent to BMS, 3/2010
Allergan buys biomaterials firm Serica, 2/2010
Allergan licenses BTG's ReGel for ophthalmic use, 12/2009
Pieris uses its Anticalin IP to help Allergan create drugs, 9/2009
Quintiles helps Allergan detail Sanctura XR in the US, 9/2009
Spectrum grants EOquin rights to Allergan, 10/2008
Allergan to develop Polyphor's cytokine blockers, 10/2008
Asterand licenses prostaglandin program to Allergan, 9/2008
Allergan buys Aczone from QLT for $150mm, 6/2008

Most Recent Related Articles

Click an article to see a free preview (15 of 99).

ASMBS Highlights New Developments in Bariatric Surgery, The Pink Sheet DAILY 8/2010
Medicare/Medicaid Prosecutions: Does More Money for Fraud Activities Translate Into More Mega-Settlements?, Medtech Insight 2/2010
AAO Highlights: Back (of the Eye) to the Future, The Pink Sheet DAILY 1/2010
Top Device Stories of the Decade, Start-Up 1/2010
Appetite for Obesity Devices Stays Strong , In Vivo 11/2009
Allergan's Botox Off-Label Promotion Suit Raises Questions, But Why Would Wall Street Care?, Medtech Insight 10/2009
New Developments in Obesity Intervention, The Pink Sheet DAILY 10/2009
Health Care Reform and Business Development: 10 Reasons It Matters, Start-Up 10/2009
Venture Eyes Ophthalmology--And Likes What It Sees, In Vivo 10/2009
Biotechs Eye Macular Degeneration, In Vivo 7/2009
Botox vs. Dysport: REMS is a New wrinkle in Big Market , Start-Up 5/2009
Medical Dermatology Gets Under VCs' Skin , In Vivo 5/2009
Aesthetics Market: Fillers May Offer Bright Spot in Tough Times, The Pink Sheet DAILY 5/2009
Exploring the Bariatric Surgery/Diabetes Link: An Interview With Francesco Rubino, MD, The Pink Sheet DAILY 3/2009
GI Dynamics: In Metabolic Disease a Device Might Trump Drugs , Start-Up 1/2009

See all 99 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.